APC12纯合错义变异导致卵母细胞减数分裂中期I停滞及女性不孕
该研究对30例反复卵母细胞成熟停滞的不孕女性行全外显子测序,在一近亲家系中发现APC12基因纯合错义突变p.R8H。体外实验和小鼠模型证实该突变为功能丧失性突变,通过破坏APC12与APC6相互作用及Securin泛素化导致卵母细胞中期I停滞,提示APC12是卵母细胞成熟停滞的致病基因。
要点
- 在反复卵母细胞成熟停滞的不孕女性中鉴定出APC12纯合错义突变p.R8H。
- 小鼠卵母细胞注射Apc12突变cRNA后中期I停滞率65.21±5.64% vs 对照组30.86±1.74%(P<.01)。
- Apc12+/-小鼠卵母细胞中期I停滞率72.29±0.51% vs 野生型23.33±5.82%(P<.01),注射Apc12 cRNA可挽救至53.44±1.20%。
核心结论
- 在一例女性患者中鉴定出APC12致病突变,并证实其是卵母细胞中期I停滞的致病因素,提示APC12作为APC/C组分在卵母细胞成熟停滞病理生理中的重要性,进而导致女性不孕。
研究设计与样本
- 对30例无已知基因变异的反复卵母细胞成熟停滞不孕女性行全外显子测序,在一近亲家系成员中鉴定出APC12基因纯合错义突变(p.R8H)作为候选。
- 实验在HEK293T细胞和小鼠卵母细胞中体外进行,采用卵母细胞显微注射、蛋白质印迹、共免疫沉淀和免疫荧光等方法。
- 构建敲低小鼠模型以验证Apc12导致卵母细胞中期I停滞的功能,使用约100只野生型C57BL/6J小鼠和50只基因编辑小鼠。
主要发现
- 在一例卵母细胞中期I停滞的不孕女性中鉴定出APC12 p.R8H。
- 小鼠卵母细胞注射Apc12突变cRNA导致中期I停滞率显著高于对照组(65.21±5.64% vs 30.86±1.74%,P<.01),伴APC12蛋白表达降低和Securin积聚;注射Apc12 cRNA的卵母细胞中期I停滞率与之相当(31.51±3.05%)。
- HEK293T细胞体外实验提示APC12 p.R8H突变破坏APC12与APC6的相互作用,并通过破坏Securin泛素化损害APC/C活性。
- 小鼠卵母细胞siRNA敲低APC12导致中期I停滞(41.65±6.10% vs 24.20±2.19%,P<.01)。
- Apc12+/-小鼠卵母细胞较野生型小鼠卵母细胞表现中期I停滞(72.29±0.51% vs 23.33±5.82%,P<.01),注射Apc12 cRNA可挽救(53.44±1.20%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oocyte maturation arrest is a leading cause of female infertility. However, the genetic variables remain largely unknown. In oocytes, the activation of anaphase-promoting complex/cyclosome (APC/C) is a critical step in the transition from meiosis I to meiosis II. However, the causal relationship between variants in APC/C components and female infertility has not been completely investigated. OBJECTIVE: This study aims to find a novel gene and its pathogenic mutation as a cause for metaphase I arrest in oocytes, thus introducing a new APC/C component for screening causes of female infertility. STUDY DESIGN: Whole-exome sequencing was performed on 30 infertile women with recurrent oocyte maturation arrest without known gene variants. A homozygous missense mutation in the APC12 gene (p.R8H) was identified as a candidate for oocyte metaphase I arrest in a consanguineous family member. The experiment was conducted in vitro with HEK293T cells and mouse oocytes. Methods such as oocyte microinjection, western blotting, co-immunoprecipitation, and immunofluorescence were used. A knockdown mouse model was generated to verify the function of Apc12 in causing oocyte metaphase I arrest. About 100 wild-type C57BL/6J mice and 50 gene-edited mice were used in this study. RESULTS: APC12 p.R8H was identified in an infertile woman with oocyte metaphase I arrest. Microinjection of Apc12 mutant cRNA in mouse oocytes caused a considerably higher rate of metaphase I stage arrest (65.21±5.64% vs 30.86±1.74%, P<.01) with decreased APC12 protein expression and Securin accumulation compared to the control group, while oocytes injected with Apc12 cRNA showed comparable metaphase I arrest rate (31.51±3.05%). This fit the phenotype we identified in our case and suggested that Apc12 p.R8H was a loss-of-function mutation leading to oocyte metaphase I arrest. The in vitro experiments in HEK293T cells suggested that the APC12 p.R8H mutation disrupted the interaction between APC12 and APC6, as well as impaired APC/C activity by disrupting Securin ubiquitination. Knocking down APC12 with siRNA in mouse oocytes led to metaphase I arrest (41.65±6.10% vs 24.20±2.19%, P<.01). Oocytes from Apc12+/- mice exhibited metaphase I arrest compared with oocytes from wild-type mice (72.29±0.51% vs 23.33±5.82%, P<.01), which could be rescued by injecting Apc12 cRNA (53.44±1.20%). CONCLUSION: We identified a pathogenic mutation in APC12 in a female patient and confirmed its relevance as a causative factor for metaphase I arrest in oocytes, implying its importance as an APC/C component in the pathophysiology of oocyte maturation arrest, which caused female infertility.
引用
- Lin Y, Wei Z, Zhang L, et al. Homozygous missense variations of APC12 cause meiotic metaphase I arrest in oocytes and female infertility. Am J Obstet Gynecol. 2024. PMID: 39542389. doi:10.1016/j.ajog.2024.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。